(Q46444002)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Circulating tumor cells in metastatic colorectal cancer: do we need an alternative cutoff? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

metastatic colon cancer

1 reference

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Bruno Vincenzi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Giuseppe Biondi-Zoccai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

P Gazzaniga

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Raimondi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

A Gradilone

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

C Nicolazzo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

O Gandini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

F Longo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

S Tomao

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

P Seminara

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

I Chimenti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

M Cristofanilli

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

L Frati

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

E Cortesi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

publication date

5 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cancer Research and Clinical Oncology

2 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

139

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

1411-1416

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

Circulating tumor cells: liquid biopsy of cancer

2 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Molecular characterization of circulating tumor cells in human metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Disseminated and circulating tumor cells in gastrointestinal oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Development of molecular biomarkers in individualized treatment of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Considerations in the development of circulating tumor cell technology for clinical use

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Circulating tumor cell count is a prognostic factor in metastatic colorectal cancer patients receiving first-line chemotherapy plus bevacizumab: a Spanish Cooperative Group for the Treatment of Digestive Tumors study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Circulating tumour cells early predict progression-free and overall survival in advanced colorectal cancer patients treated with chemotherapy and targeted agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-013-1450-0

Circulating tumor cells, colon cancer and bevacizumab: the meaning of zero

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23736274

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00432-013-1450-0

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json

release_kirrewa6ijgk3bmsy6nvzmkuli

2 March 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/kirrewa6ijgk3bmsy6nvzmkuli

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23736274%20AND%20SRC:MED&resulttype=core&format=json